The key question is narrower than “When will Anthropic file?” or “When will the IPO be priced?” Polymarket resolves on the first day Anthropic shares are actually listed and open for regular-way trading on a public securities exchange. That makes the final exchange debut—not a confidential filing, public prospectus, roadshow, pricing announcement, or rumored target date—the decisive event.

The latest evidence is unusually time-sensitive. Anthropic officially confirmed a confidential draft S-1 on June 1. On September 4, Reuters reported that the company now expects to begin marketing the IPO in mid-October at the earliest, with a public prospectus expected in late September and the listing expected to finish only days before the U.S. midterm elections in November. That reported shift explains why November has gained rapidly even though October remains the market leader.

If you are new to prediction-market pricing, start with How Prediction Markets Work?. A market price is a crowd signal, not a guaranteed real-world probability.

What This Polymarket Market Asks

Verified market rule: The event is titled “In which month will Anthropic IPO?” and contains 17 mutually exclusive calendar outcomes: September through December 2026, every month from January through December 2027, and No IPO before 2028.

The winning month is the calendar month in Eastern Time containing the first day on which Anthropic shares are listed and open for regular-way trading on a public securities exchange. A traditional IPO or a direct listing counts. A merger, acquisition, absorption, or SPAC transaction into an already public entity does not count as an IPO month for this market; in that case the market resolves to No IPO before 2028.

Resolution Rules and What Counts

• What counts: the first day of regular-way public trading in ET.
• Traditional IPO: counts.
• Direct listing: counts.
• Merger / acquisition / absorption into an already public company, including a SPAC: resolves to “No IPO before 2028.”
• Hard fallback: if no qualifying IPO occurs by December 31, 2027 at 11:59 PM ET, the market resolves to “No IPO before 2028.”
• Filings and announcements: do not resolve the market by themselves.
• Resolution source: information from the primary exchange.

This rule set creates an important timing edge case: Anthropic could publicly file, launch a roadshow, price the IPO, or announce an intended October debut and still resolve to November if the first regular trading session begins in November.

Current Market Snapshot

Market-implied snapshot: The Polymarket page retrieved for this analysis showed approximately $162,786 in total market volume. The headline display had October well ahead, but November had become a meaningful challenger:

These are raw values from separate binary contracts, so the displayed percentages and quoted prices are not a perfectly normalized probability distribution and can sum to more than 100%. I therefore use them as a measure of trader conviction rather than as a clean probability vector.

Main Outcomes

October 2026 — the current base case

October fits the latest reported sequence better than any other month. Reuters reported that Anthropic’s public prospectus is now expected in late September and that IPO marketing is expected to begin in mid-October at the earliest. It also reported that the listing is expected to complete days before the U.S. midterm elections in November. If that timetable holds without meaningful slippage, the first public trading day can still fall in the final part of October.

The company also looks operationally prepared for a large offering. Anthropic officially said on May 28 that it raised $65 billion in Series H financing at a $965 billion post-money valuation and that run-rate revenue had crossed $47 billion earlier that month. On June 1, Anthropic publicly confirmed that it had confidentially submitted a draft S-1 to the SEC.

November 2026 — the main challenger

November is the most important risk to the October thesis. The phrase “mid-October at the earliest” matters. A marketing launch in the middle of October leaves a compressed window for book-building, final amendments, pricing, exchange readiness, and the first regular trading session before the calendar rolls into November.

SEC guidance also matters here. For issuers using the nonpublic draft-registration process, the public filing generally must occur at least 15 days before the roadshow. A late-September prospectus followed by a mid-October roadshow is internally consistent with that rule—but it does not leave much calendar buffer if comments, valuation negotiations, market volatility, or logistics move by even several trading days.

September 2026 — now a very low-probability path

September would require the current reported timetable to reverse sharply. Reuters says the public prospectus is no longer expected until late September and marketing is now expected to begin in mid-October at the earliest. Because Polymarket resolves on actual trading, not filing, the September contract has little support from the latest sequence.

December 2026 and the 2027 tail

Later outcomes become relevant if the offering encounters a more serious delay: additional SEC work, a change in valuation strategy, a major risk-off move in public markets, financing complications, or a decision by Anthropic and its banks to wait for a cleaner window. Those possibilities are real, but the confidential filing, reported bank work, and reported autumn launch plan keep them in the tail of my model.

Key Factors

Primary factors

• Reported IPO timetable. The latest Reuters timetable is the single strongest month-specific signal.
• SEC and prospectus timing. Public filing and roadshow sequencing determine how much room remains before November.
• Underwriting and financing readiness. Reuters reports Morgan Stanley, Goldman Sachs, JPMorgan, and Citi are among the banks working with Anthropic, alongside work to finalize a $15 billion revolving credit facility.

Secondary factors

• Market and valuation execution risk. Reuters reported that some investors have discussed a valuation as high as $2 trillion. That is not an official target, but an offering of this scale can require careful price discovery.
• Company readiness and investor demand. Anthropic’s private valuation, revenue scale, and large financing rounds support the idea that it can execute a major public offering if the market window remains open.
• Exchange-day mechanics. The first regular trading day controls resolution; a pricing date near month-end is not enough.

Weighted Outcome Comparison

Analytical assumption: I score five timing scenarios from 1 to 10 across five decision-relevant factors. The weights total exactly 100%. I did not tune these scores to match Polymarket’s prices.

The framework gives October a meaningful but not overwhelming advantage. The main reason is that the latest timetable explicitly points toward a late-October completion, while the main uncertainty is execution compression: a few extra days of SEC, marketing, valuation, or exchange work can move the first trading day across the month boundary.

Company and IPO Evidence Analysis

Anthropic has already crossed the most important early filing milestone

Verified fact: Anthropic announced on June 1 that it had confidentially submitted a draft Form S-1 to the SEC. The company said this gives it the option to go public after SEC review and emphasized that the offering depends on market conditions and other factors. It did not announce a listing date, share count, or price.

The company’s private-market scale supports near-term readiness

Verified fact: On May 28, Anthropic announced a $65 billion Series H at a $965 billion post-money valuation and said run-rate revenue had crossed $47 billion. Those figures do not determine the IPO month, but they matter because a company with this scale has strong incentives and resources to maintain a large underwriting and investor-relations process.

The September timetable shift is the decisive new evidence

Credible reporting: Reuters reported on September 4 that Anthropic is expected to begin marketing the IPO in mid-October at the earliest and complete the listing only days before the U.S. midterms in November. The report said the prospectus had previously been expected sooner but is now not expected until late September. Reuters also cautioned that plans remain subject to change.

That report is the main reason I do not simply copy the 71% October market price into my own model. An October listing still makes the most sense, but the schedule is close enough to month-end that November deserves a larger independent probability than a casual reading of “October favorite” might suggest.

SEC timing rules explain why late September matters

The SEC’s voluntary draft-registration guidance says an issuer conducting an IPO must publicly file its registration statement and prior nonpublic draft submissions at least 15 days before conducting its roadshow, or at least 15 days before the effective date if there is no roadshow. That is a general rule, not an Anthropic-specific deadline, but it gives structure to the Reuters sequence: late-September public filing followed by a mid-October roadshow is plausible.

The overall process length is not abnormal

The NYSE’s general IPO guide says planning and executing an IPO typically takes 16–20 weeks or more from organizational meeting to closing, depending on readiness, transaction complexity, market conditions, and other factors. Anthropic’s June confidential filing to an October/November debut sits inside a normal large-IPO process window. I use this only as process context, not as evidence that Anthropic will list on the NYSE.

What the Market May Be Underestimating

The market may be underestimating calendar-boundary risk. October at 71% looks dominant, but the underlying reported schedule is not “listing in mid-October.” It is marketing in mid-October at the earliest, with the actual listing expected later. For this market, a delay of one week can matter more than a delay of one month would in a broader “IPO by year-end” contract.

The second issue is valuation execution. Reuters reported that some investors have discussed a valuation as high as $2 trillion. Anthropic has not announced an official IPO valuation, so this is not a hard data point. But the bigger the valuation gap between the latest $965 billion private round and the proposed public-market target, the more important investor price discovery becomes.

The third is rule precision. A public S-1, completed roadshow, or announced pricing does not win October unless regular trading actually starts in October. Traders who focus on press milestones rather than the first trading day can misread the contract.

Bull/Bear Case for Major Outcomes

October 2026 bull case

• Public prospectus appears in late September as reported.
• SEC review and amendments are sufficiently advanced from the confidential process.
• Analyst education and roadshow work can be compressed because major banks already know the company.
• Investor demand is strong enough to price and begin trading in the final part of October.

October 2026 bear case

• The public prospectus slips from late September.
• Final SEC comments or disclosure changes consume the limited buffer.
• Valuation discussions require a longer marketing period.
• Market volatility pushes pricing or first trading into early November.

November 2026 bull case

• Anthropic remains on the same broad autumn IPO path, but one or two execution steps take longer than the aggressive October schedule allows.
• The company chooses a slightly wider roadshow window to improve price discovery for a very large offering.
• A late-October pricing schedule produces the first regular trading session in November.

November 2026 bear case

• The company and banks are strongly motivated to complete before the November political calendar and successfully compress the final stages.
• SEC review is already sufficiently mature from the confidential process to avoid late surprises.

December 2026 or later bull case

• A major risk-off event, valuation disagreement, disclosure issue, or regulatory delay forces a reset.
• Anthropic decides the late-2026 market window is not attractive enough and waits.

Risks and Uncertainties

• Reported timing is not official guidance. Reuters’ sources are credible, but Anthropic declined to comment on the September 4 timetable.
• Confidential SEC review is nonpublic. Outside observers do not know the remaining comment burden or exact readiness of the registration statement.
• Market conditions can change quickly. Large growth IPOs are especially sensitive to risk appetite and comparable-company performance.
• Valuation is unsettled. Anthropic has not publicly set the number of shares or IPO price.
• Exchange choice should not be assumed. The Polymarket rule resolves from the primary exchange; this analysis does not assume Nasdaq or NYSE unless publicly confirmed.
• Prediction-market prices are dynamic. The October/November split can move rapidly as new filing or roadshow evidence appears.

PredictBoy Probability Assessment

PredictBoy analysis — not fact: My probability distribution is:

Market Odds vs. PredictBoy

The biggest difference is not the identity of the leader—it is the width of the October advantage. Polymarket’s displayed October probability was 71%, while I assign 64%. I shift most of that difference into November, raising it from the market’s 26.8% display to 31% in my model.

That is a small but deliberate disagreement. I think traders are correctly focused on October, but the reported “mid-October at the earliest” marketing start leaves less buffer than a 71% month-specific probability might suggest.

What Could Change Before Resolution

• Public S-1 / prospectus timing: a filing earlier or later than the reported late-September target is the fastest way to move the month probabilities.
• Roadshow launch date: confirmation of mid-October marketing would tighten the listing window.
• Exchange and ticker announcement: confirms another operational milestone but still does not resolve the market.
• SEC amendments / effectiveness: unusually fast progress favors October; additional amendment cycles favor November or later.
• IPO size and valuation: a narrower, easier-to-clear deal can speed execution; a very aggressive valuation can extend price discovery.
• Broader market conditions: sharp volatility or weak comparable-company trading could change the launch window quickly.
• First day of regular trading: this is the only milestone that finally determines the winning month.

Primary factors: the reported timetable, SEC/public-filing sequence, and underwriting readiness. Secondary factors: valuation execution, investor demand, market conditions, and exchange-day mechanics. Overall probability outlook: October remains the base case, with November the only close-to-core alternative.

Final Take

PredictBoy analysis — not fact: I still make October 2026 the most likely Anthropic IPO month, but I am less confident than the raw Polymarket display. The confidential S-1, financing scale, bank involvement, and reported autumn launch plan all support a 2026 debut. The problem is the calendar: a late-September prospectus and mid-October marketing start leave a relatively narrow path to get regular trading underway before November.

My base case is therefore October 64%, with November 31% as the main risk. The next public prospectus or roadshow confirmation should matter far more than another rumor about valuation. For this contract, the question is not whether Anthropic looks IPO-ready—it is whether the first trading day lands on one side or the other of the October/November boundary.

Sources

• Polymarket — In which month will Anthropic IPO?
• Anthropic — Confidential draft S-1 submission, June 1, 2026
• Anthropic — Series H funding announcement, May 28, 2026
• Reuters — Anthropic IPO launch shifts toward mid-October, September 4, 2026
• U.S. SEC — Voluntary Submission of Draft Registration Statements FAQs
• NYSE — IPO Guide / process overview

Disclosure: This article provides prediction-market analysis and educational context. It is not financial, investment, legal, or trading advice.